ID   PLCB2_HUMAN             Reviewed;        1185 AA.
AC   Q00722; A8K6J2; B9EGH5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-beta-2;
DE   AltName: Full=Phospholipase C-beta-2;
DE            Short=PLC-beta-2;
GN   Name=PLCB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1644792;
RA   Park D., Jhon D.-Y., Kriz R., Knopf J., Rhee S.G.;
RT   "Cloning, sequencing, expression, and Gq-independent activation of
RT   phospholipase C-beta 2.";
RL   J. Biol. Chem. 267:16048-16055(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-1095.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-953, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-803 (ISOFORM 2) IN COMPLEX
RP   WITH RAC1, AND MUTAGENESIS OF GLN-52.
RX   PubMed=17115053; DOI=10.1038/nsmb1175;
RA   Jezyk M.R., Snyder J.T., Gershberg S., Worthylake D.K., Harden T.K.,
RA   Sondek J.;
RT   "Crystal structure of Rac1 bound to its effector phospholipase C-
RT   beta2.";
RL   Nat. Struct. Mol. Biol. 13:1135-1140(2006).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by activated phosphatidylinositol-specific phospholipase
CC       C enzymes.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 1 Ca(2+) ion per subunit.;
CC   -!- SUBUNIT: Interacts with RAC1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q00722-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00722-2; Sequence=VSP_035770;
CC       Name=3;
CC         IsoId=Q00722-3; Sequence=VSP_054490;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: The receptor-mediated activation of PLC-beta-2 is
CC       most effectively mediated by one G-protein alpha subunit, alpha-
CC       16.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLCB2ID41743ch15q15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M95678; AAA36453.1; -; mRNA.
DR   EMBL; AK291657; BAF84346.1; -; mRNA.
DR   EMBL; AC020658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136467; AAI36468.1; -; mRNA.
DR   CCDS; CCDS42020.1; -. [Q00722-1]
DR   CCDS; CCDS61591.1; -. [Q00722-3]
DR   CCDS; CCDS61592.1; -. [Q00722-2]
DR   PIR; A43346; A43346.
DR   RefSeq; NP_001271226.1; NM_001284297.1. [Q00722-2]
DR   RefSeq; NP_001271227.1; NM_001284298.1. [Q00722-3]
DR   RefSeq; NP_004564.2; NM_004573.2. [Q00722-1]
DR   UniGene; Hs.355888; -.
DR   PDB; 2FJU; X-ray; 2.20 A; B=1-803.
DR   PDB; 2ZKM; X-ray; 1.62 A; X=1-803.
DR   PDBsum; 2FJU; -.
DR   PDBsum; 2ZKM; -.
DR   ProteinModelPortal; Q00722; -.
DR   SMR; Q00722; -.
DR   BioGrid; 111346; 13.
DR   DIP; DIP-29259N; -.
DR   MINT; MINT-1726830; -.
DR   STRING; 9606.ENSP00000260402; -.
DR   SwissLipids; SLP:000000948; -.
DR   iPTMnet; Q00722; -.
DR   PhosphoSitePlus; Q00722; -.
DR   BioMuta; PLCB2; -.
DR   DMDM; 215273902; -.
DR   EPD; Q00722; -.
DR   MaxQB; Q00722; -.
DR   PaxDb; Q00722; -.
DR   PeptideAtlas; Q00722; -.
DR   PRIDE; Q00722; -.
DR   DNASU; 5330; -.
DR   Ensembl; ENST00000260402; ENSP00000260402; ENSG00000137841. [Q00722-1]
DR   Ensembl; ENST00000456256; ENSP00000411991; ENSG00000137841. [Q00722-3]
DR   Ensembl; ENST00000557821; ENSP00000453975; ENSG00000137841. [Q00722-2]
DR   GeneID; 5330; -.
DR   KEGG; hsa:5330; -.
DR   UCSC; uc001zld.4; human. [Q00722-1]
DR   CTD; 5330; -.
DR   DisGeNET; 5330; -.
DR   GeneCards; PLCB2; -.
DR   H-InvDB; HIX0012125; -.
DR   HGNC; HGNC:9055; PLCB2.
DR   HPA; CAB009443; -.
DR   HPA; HPA041298; -.
DR   MIM; 604114; gene.
DR   neXtProt; NX_Q00722; -.
DR   OpenTargets; ENSG00000137841; -.
DR   PharmGKB; PA33385; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000232046; -.
DR   HOVERGEN; HBG053609; -.
DR   InParanoid; Q00722; -.
DR   KO; K05858; -.
DR   OMA; YEPSGIN; -.
DR   OrthoDB; EOG091G00XL; -.
DR   PhylomeDB; Q00722; -.
DR   TreeFam; TF313216; -.
DR   BioCyc; MetaCyc:HS06408-MONOMER; -.
DR   BRENDA; 3.1.4.11; 2681.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-HSA-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418217; G beta:gamma signalling through PLC beta.
DR   Reactome; R-HSA-434316; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion.
DR   Reactome; R-HSA-500657; Presynaptic function of Kainate receptors.
DR   SABIO-RK; Q00722; -.
DR   SignaLink; Q00722; -.
DR   SIGNOR; Q00722; -.
DR   ChiTaRS; PLCB2; human.
DR   EvolutionaryTrace; Q00722; -.
DR   GeneWiki; PLCB2; -.
DR   GenomeRNAi; 5330; -.
DR   PRO; PR:Q00722; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137841; -.
DR   CleanEx; HS_PLCB2; -.
DR   ExpressionAtlas; Q00722; baseline and differential.
DR   Genevisible; Q00722; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IMP:AgBase.
DR   GO; GO:0004629; F:phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:ProtInc.
DR   GO; GO:0050913; P:sensory perception of bitter taste; IEA:Ensembl.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016280; PLC-beta.
DR   InterPro; IPR028403; PLC-beta2.
DR   InterPro; IPR014815; PLC-beta_C.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF122; PTHR10336:SF122; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   Pfam; PF08703; PLC-beta_C; 1.
DR   PIRSF; PIRSF000956; PLC-beta; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Coiled coil;
KW   Complete proteome; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transducer.
FT   CHAIN         1   1185       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase beta-2.
FT                                /FTId=PRO_0000088489.
FT   DOMAIN      312    463       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      546    662       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      669    767       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   COILED      988   1147       {ECO:0000255}.
FT   COMPBIAS    500    545       Glu-rich.
FT   ACT_SITE    327    327       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    374    374       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       328    328       Calcium.
FT   METAL       357    357       Calcium.
FT   METAL       359    359       Calcium.
FT   METAL       408    408       Calcium.
FT   MOD_RES     953    953       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     492    495       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1644792}.
FT                                /FTId=VSP_035770.
FT   VAR_SEQ     868    882       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054490.
FT   VARIANT     324    324       N -> I (in dbSNP:rs45628633).
FT                                /FTId=VAR_047509.
FT   VARIANT     598    598       R -> H (in dbSNP:rs8025153).
FT                                /FTId=VAR_047510.
FT   VARIANT     664    664       P -> L (in dbSNP:rs9972332).
FT                                /FTId=VAR_047511.
FT   VARIANT     712    712       G -> R (in dbSNP:rs28395835).
FT                                /FTId=VAR_047512.
FT   VARIANT    1095   1095       E -> G (in dbSNP:rs936212).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_047513.
FT   MUTAGEN      52     52       Q->A: Strongly reduces interaction with
FT                                RAC1. {ECO:0000269|PubMed:17115053}.
FT   CONFLICT    119    119       K -> R (in Ref. 2; BAF84346).
FT                                {ECO:0000305}.
FT   CONFLICT   1060   1060       K -> R (in Ref. 2; BAF84346).
FT                                {ECO:0000305}.
FT   HELIX        15     19       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       21     26       {ECO:0000244|PDB:2ZKM}.
FT   TURN         28     30       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       33     40       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       46     51       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       56     60       {ECO:0000244|PDB:2ZKM}.
FT   HELIX        61     63       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       64     69       {ECO:0000244|PDB:2ZKM}.
FT   HELIX        70     72       {ECO:0000244|PDB:2ZKM}.
FT   HELIX        79     84       {ECO:0000244|PDB:2ZKM}.
FT   TURN         85     88       {ECO:0000244|PDB:2FJU}.
FT   HELIX        94     96       {ECO:0000244|PDB:2ZKM}.
FT   STRAND       98    103       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      105    109       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      111    121       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       122    135       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       139    141       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       144    157       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       167    173       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       178    187       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      193    195       {ECO:0000244|PDB:2FJU}.
FT   HELIX       200    202       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       205    215       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       219    222       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       238    247       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       267    274       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       288    296       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       305    308       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       318    320       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      321    323       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      325    328       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      331    333       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      335    338       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       343    350       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      355    361       {ECO:0000244|PDB:2ZKM}.
FT   TURN        365    368       {ECO:0000244|PDB:2FJU}.
FT   HELIX       384    394       {ECO:0000244|PDB:2ZKM}.
FT   TURN        395    397       {ECO:0000244|PDB:2FJU}.
FT   STRAND      403    409       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       414    428       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       429    431       {ECO:0000244|PDB:2ZKM}.
FT   TURN        451    456       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      458    461       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       523    531       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       534    538       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       544    547       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       561    567       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      572    577       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       578    587       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       589    598       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      599    604       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       618    622       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      626    628       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       637    645       {ECO:0000244|PDB:2ZKM}.
FT   TURN        646    648       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       649    651       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      653    656       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       659    661       {ECO:0000244|PDB:2ZKM}.
FT   TURN        675    680       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      682    693       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      701    708       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      724    726       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      738    745       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       746    748       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      750    757       {ECO:0000244|PDB:2ZKM}.
FT   TURN        758    760       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      761    769       {ECO:0000244|PDB:2ZKM}.
FT   HELIX       770    772       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      776    783       {ECO:0000244|PDB:2ZKM}.
FT   STRAND      789    802       {ECO:0000244|PDB:2ZKM}.
SQ   SEQUENCE   1185 AA;  134024 MW;  A0397309D943672A CRC64;
     MSLLNPVLLP PKVKAYLSQG ERFIKWDDET TVASPVILRV DPKGYYLYWT YQSKEMEFLD
     ITSIRDTRFG KFAKMPKSQK LRDVFNMDFP DNSFLLKTLT VVSGPDMVDL TFHNFVSYKE
     NVGKAWAEDV LALVKHPLTA NASRSTFLDK ILVKLKMQLN SEGKIPVKNF FQMFPADRKR
     VEAALSACHL PKGKNDAINP EDFPEPVYKS FLMSLCPRPE IDEIFTSYHA KAKPYMTKEH
     LTKFINQKQR DSRLNSLLFP PARPDQVQGL IDKYEPSGIN AQRGQLSPEG MVWFLCGPEN
     SVLAQDKLLL HHDMTQPLNH YFINSSHNTY LTAGQFSGLS SAEMYRQVLL SGCRCVELDC
     WKGKPPDEEP IITHGFTMTT DIFFKEAIEA IAESAFKTSP YPIILSFENH VDSPRQQAKM
     AEYCRTIFGD MLLTEPLEKF PLKPGVPLPS PEDLRGKILI KNKKNQFSGP TSSSKDTGGE
     AEGSSPPSAP AGEGTVWAGE EGTELEEEEV EEEEEEESGN LDEEEIKKMQ SDEGTAGLEV
     TAYEEMSSLV NYIQPTKFVS FEFSAQKNRS YVISSFTELK AYDLLSKASV QFVDYNKRQM
     SRIYPKGTRM DSSNYMPQMF WNAGCQMVAL NFQTMDLPMQ QNMAVFEFNG QSGYLLKHEF
     MRRPDKQFNP FSVDRIDVVV ATTLSITVIS GQFLSERSVR TYVEVELFGL PGDPKRRYRT
     KLSPSTNSIN PVWKEEPFVF EKILMPELAS LRVAVMEEGN KFLGHRIIPI NALNSGYHHL
     CLHSESNMPL TMPALFIFLE MKDYIPGAWA DLTVALANPI KFFSAHDTKS VKLKEAMGGL
     PEKPFPLASP VASQVNGALA PTSNGSPAAR AGAREEAMKE AAEPRTASLE ELRELKGVVK
     LQRRHEKELR ELERRGARRW EELLQRGAAQ LAELGPPGVG GVGACKLGPG KGSRKKRSLP
     REESAGAAPG EGPEGVDGRV RELKDRLELE LLRQGEEQYE CVLKRKEQHV AEQISKMMEL
     AREKQAAELK ALKETSENDT KEMKKKLETK RLERIQGMTK VTTDKMAQER LKREINNSHI
     QEVVQVIKQM TENLERHQEK LEEKQAACLE QIREMEKQFQ KEALAEYEAR MKGLEAEVKE
     SVRACLRTCF PSEAKDKPER ACECPPELCE QDPLIAKADA QESRL
//
